New onset depression in autoimmune patients and the relationship with their biologics

Sue Overton, MUS Team Administrator, Medicines Use and Safety (SPS)Event 16 March 2022Location Online via Webex 13.00 - 14.00

16 March 2022. An MUS Webinar with a discussion between specialist pharmacists

Date

16 March 2022

Location

Online via Webex 13.00 - 14.00

About the Event

Our speakers shared their experiences of patients with autoimmune disease related depression and anti-TNF depression.  The session explored the results from a question delivered via a social media platform to gain a broad understanding of current knowledge and potential opportunities for learning and upskilling healthcare professionals in this area.

Why it’s important

Pharmacists across sectors are in a position to identify patients who may have developed side effects to a newly prescribed anti-TNF medicine, especially those experiencing depression. This is a very important topic to raise awareness as it can have a negative impact on patient’s lives.

What was covered

The webinar focused on:

  • Discussing the results from a question delivered via social media about anti-TNFs and depression as an adverse drug reaction.
  • Discussing depression as an adverse drug reaction in patients with chronic disease.
  • Discussing IBD standards and psychology service in Brighton and Cambridge.

Speakers

Our speakers today include experts from SPS and other organisations.

SPS Speakers

Today’s webinar was led by Denise and facilitated by Nicola.  You can read more about them below:

Non-SPS Speakers

Anja St. Clair Jones

Consultant Pharmacist Gastroenterology, University Hospital Sussex NHSFT

Recording

A recording of the webinar is now available

Contact us

Please contact the Admin Team if you have any questions.